首页 › 基金 › Redmile Group, LLC › GRTX

Redmile Group, LLC 对 GRTX 的持仓历史

ELECTRA THERAPEUTICS INC

Redmile Group, LLC 在 Q3 2026 的 13F 申报中披露持有 GRTX(ELECTRA THERAPEUTICS INC)5,430,918 股,市值约 US$61.1M,约占其申报组合的 4.47%,在其申报持仓中市值排名第 7 位。 Redmile Group, LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)5.43M 股
申报持仓市值$61.10M
组合权重4.47%
首次申报Q3 2026
最近变动新进
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Redmile Group, LLC 对 GRTX 的持仓演变

Redmile Group, LLC 于 Q3 2026 首次披露 GRTX 持仓:5,430,918 股(约 US$61.1M)。

逐季持仓明细

季度股数金额变化
Q3 2026 5.43M $61.10M 新进

关于 GRTX 与 13F 数据

GRTX(ELECTRA THERAPEUTICS INC)的行业分类暂缺。我们追踪的基金中还有 57 只申报持有 GRTX,申报仓位最大的包括:ORBIMED ADVISORS LLC (US$77.5M), EQT Fund Management S.a r.l. (US$42.7M), Cormorant Asset Management, LP (US$37.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 GRTX 的基金

查看 GRTX 的全部基金持有人 →

常见问题

How long has Redmile Group, LLC held GRTX?

Redmile Group, LLC has disclosed GRTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Redmile Group, LLC's current position in GRTX?

As of Q3 2026, Redmile Group, LLC holds 5.43M shares of GRTX (ELECTRA THERAPEUTICS INC), valued at $61.10M, representing 4.47% of its reported portfolio and ranking #7.

Has Redmile Group, LLC been buying or selling GRTX?

In the latest 13F filing (Q3 2026), Redmile Group, LLC newly opened its position in GRTX.

Which other funds hold GRTX?

Other major institutional holders of GRTX include ORBIMED ADVISORS LLC, EQT Fund Management S.a r.l., Cormorant Asset Management, LP, among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.